CompletedNCT00327236
The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes
Studying Paraneoplastic neurologic syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rockefeller University
- Principal Investigator
- Robert Darnell, MD, PHD, M.D., Ph.DRockefeller University
- Enrollment
- 109 target
- Eligibility
- 1 years · All sexes
- Timeline
- 1995 – 2018
Study locations (1)
- Rockefeller University Hospital, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00327236 on ClinicalTrials.govOther trials for Paraneoplastic neurologic syndrome
Additional recruiting or active studies for the same condition.